Autofluorescence and Indocyanine Green to Avoid Hypocalcemia After Thyroidectomy

Launched by ONZE LIEVE VROUW HOSPITAL · Nov 2, 2021

Keywords

ClinConnect Summary

This clinical trial is studying a new approach to help prevent low calcium levels (hypocalcemia) after thyroid surgery, which is a common issue that can occur when the parathyroid glands are not identified and preserved during the procedure. Researchers are testing the use of special light technology, called autofluorescence, along with a dye called indocyanine green, which can highlight the parathyroid glands and show their blood supply. The goal is to see if these techniques can help doctors better identify the parathyroid glands during surgery and reduce the chances of patients experiencing low calcium levels afterward.

To participate in this trial, you need to be an adult (ages 65 to 74) who is scheduled for a total thyroidectomy and has not had any previous neck surgeries. Unfortunately, younger patients, those who have had prior neck surgery, or those with certain allergies to the dye cannot join. Participants will receive the standard surgical care but will also have the added benefit of this new technology being used during their surgery. This study is currently recruiting participants and aims to provide insights that could improve outcomes for future thyroid surgery patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All adult patients undergoing a total thyroidectomy without previous neck surgery.
• Exclusion Criteria:
• • Children and teenagers (\<18 years old)
• • Patients refusing participation or unable/unwilling to sign the informed consent
• • Patients with a completion thyroidectomy
• • Patients with planned central and lateral neck lymph node dissections (thyroid cancer)
• • Patients with previous neck surgery
• • Patients with a known allergy/hypersensitivity to indocyanine green